TECH Profile
Bio-Techne Corporation, based in Minneapolis, Minnesota, is a global leader in the development, manufacturing, and distribution of life science reagents, instruments, and services for both research and clinical diagnostic markets. Founded in 1976 and formerly known as Techne Corporation, the company rebranded as Bio-Techne Corporation in November 2014.
The company operates through two primary segments: Protein Sciences and Diagnostics and Genomics. Under the Protein Sciences segment, Bio-Techne specializes in the development of biological reagents critical for life science research, diagnostics, and therapies, including cytokines, growth factors, antibodies, and cell selection technologies. Additionally, it provides proteomic analytical tools and immunoassays for protein quantification, supporting automated western blot and multiplexed ELISA workflows.
In its Diagnostics and Genomics segment, Bio-Techne manufactures a wide range of diagnostic products such as controls, calibrators, and assays tailored for regulated diagnostic markets. The segment also offers exosome-based molecular diagnostics, tissue-based assays for genomic analysis, and kits for genetic and oncology research and clinical applications. Furthermore, Bio-Techne provides instruments and process control products essential for hematology, blood chemistry, gases, and coagulation, reinforcing its commitment to advancing diagnostic capabilities.
Bio-Techne's portfolio includes well-known brands like R&D Systems, Tocris Biosciences, Novus Biologicals, ProteinSimple, Advanced Cell Diagnostics, Exosome Diagnostics, and Asuragen. With a strong emphasis on innovation and customer-centric solutions, the company continues to expand its global footprint and enhance its offerings across diverse segments of the life sciences industry.
|
